IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
2.040
-0.130 (-5.99%)
At close: Oct 2, 2026, 4:00 PM EDT
2.010
-0.030 (-1.47%)
After-hours: Oct 2, 2026, 7:59 PM EDT
IM Cannabis Revenue
IM Cannabis had revenue of 7.59M CAD in the quarter ending June 30, 2026, a decrease of -40.23%. This brings the company's revenue in the last twelve months to 45.80M, down -12.61% year-over-year. In the year 2025, IM Cannabis had annual revenue of 54.73M with 1.30% growth.
Revenue (ttm)
45.80M CAD
Revenue Growth
-12.61%
P/S Ratio
0.10
Revenue / Employee
1,040,977 CAD
Employees
44
Market Cap
3.36M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.73M | 700.00K | 1.30% |
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
| Dec 31, 2019 | 9.07M | 3.88M | 74.60% |
| Dec 31, 2018 | 5.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biofrontera | 46.18M |
| Sunshine Biopharma | 35.35M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| InMed Pharmaceuticals | 4.94M |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
| Akanda | 258.08K |
IMCC News
- 4 days ago - IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet - PRNewsWire
- 8 days ago - IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares - PRNewsWire
- 9 days ago - IM Cannabis regains compliance with Nasdaq minimum bid price requirement - TheFly
- 9 days ago - IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 10 days ago - IM Cannabis prices 655,000 shares at $2.00 in registered direct offering - TheFly
- 10 days ago - IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares - PRNewsWire
- 10 days ago - IM Cannabis announces LOI to acquire 51% of Space Defense Innovations - TheFly
- 10 days ago - IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market - PRNewsWire